GlassScriptPhysician profile
Amy Donnelly
NPI 1871077255
$36,396.20
in general payments reported to CMS, 2019-2025
38 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,170 · 2022: $1,958 · 2023: $1,738 · 2024: $568 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $7,603 · Honoraria: $4,485 · Food and Beverage: $3,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,260.00 |
| Travel and Lodging | $7,602.57 |
| Honoraria | $4,485.00 |
| Food and Beverage | $3,920.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $32,490.42 | 2022-2025 | Korlym |
| Abbvie INC. | $836.10 | 2021-2023 | |
| Novo Nordisk INC | $647.06 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $264.13 | 2021-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $227.16 | 2021-2024 | Xarelto |
| Pfizer INC. | $159.45 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $145.80 | 2021-2023 | Breztri, Farxiga |
| Amgen INC. | $144.49 | 2021-2023 | Otezla |
| Abbott Laboratories | $140.23 | 2023-2025 | Freestyle Libre 3, Cardiomems |
| Boston Scientific Corporation | $136.21 | 2024 | Watchman Access System |
| Glaxosmithkline, LLC. | $131.33 | 2021-2023 | Trelegy Ellipta |
| Ironshore Pharmaceuticals INC. | $107.41 | 2022-2023 | Jornay Pm |
| Dexcom, INC. | $84.18 | 2022-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $82.89 | 2021-2023 | Steglatro |
| Axsome Therapeutics, INC. | $77.81 | 2022-2023 | Auvelity |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Donnelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.